• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠-脑轴失调在非酒精性脂肪性肝病发病机制中的作用:机制与治疗意义

Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications.

作者信息

Wan Mei, Zhao Weimin, Cai Yifan, He Qian, Zeng Jun

机构信息

The First Clinical Medical College of China Three Gorges University, Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, Yichang Central People's Hospital Yichang 443000, Hubei, China.

Yichang Key Laboratory of Endocrinology Yichang 443000, Hubei, China.

出版信息

Am J Transl Res. 2025 May 15;17(5):3276-3292. doi: 10.62347/ZWSR4476. eCollection 2025.

DOI:10.62347/ZWSR4476
PMID:40535646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12170361/
Abstract

Non-alcoholic fatty liver disease (NAFLD) has emerged as a global health challenge due to its rising prevalence and strong association with metabolic syndrome. Recent studies highlight the critical role of the gut-brain axis (GBA)-a bidirectional communication system between the gut, brain, and liver-in NAFLD pathogenesis. Dysregulation of this axis can worsen metabolic dysfunction, inflammation, and liver injury. This review discusses the mechanisms driving GBA dysregulation in NAFLD, including alterations in gut microbiota, increased intestinal permeability, neuroinflammation, and imbalances in the autonomic nervous system (ANS). We also explore therapeutic strategies, such as microbiota modulation, vagus nerve stimulation, and neuroprotective interventions, that may help mitigate the effects of GBA dysfunction on NAFLD progression.

摘要

非酒精性脂肪性肝病(NAFLD)因其患病率不断上升以及与代谢综合征的密切关联,已成为一项全球性的健康挑战。近期研究突显了肠-脑轴(GBA)——肠道、大脑和肝脏之间的双向通信系统——在NAFLD发病机制中的关键作用。该轴的失调会加剧代谢功能障碍、炎症和肝损伤。本综述讨论了NAFLD中驱动GBA失调的机制,包括肠道微生物群的改变、肠道通透性增加、神经炎症以及自主神经系统(ANS)失衡。我们还探讨了治疗策略,如微生物群调节、迷走神经刺激和神经保护干预措施,这些策略可能有助于减轻GBA功能障碍对NAFLD进展的影响。

相似文献

1
Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications.肠-脑轴失调在非酒精性脂肪性肝病发病机制中的作用:机制与治疗意义
Am J Transl Res. 2025 May 15;17(5):3276-3292. doi: 10.62347/ZWSR4476. eCollection 2025.
2
Radiation-induced injury and the gut microbiota: insights from a microbial perspective.辐射诱导损伤与肠道微生物群:从微生物视角的见解
Therap Adv Gastroenterol. 2025 Jun 16;18:17562848251347347. doi: 10.1177/17562848251347347. eCollection 2025.
3
Bacterial extracellular vesicles in the brain: Pathological effects and therapeutic possibilities.大脑中的细菌细胞外囊泡:病理影响与治疗潜力
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-25-00236.
4
Gut microbiota and Parkinson's Disease: a new frontier in understanding neurological health.肠道微生物群与帕金森病:理解神经健康的新前沿。
Inflammopharmacology. 2025 Apr 17. doi: 10.1007/s10787-025-01726-w.
5
Gut microbiota and autism spectrum disorder: advances in dietary intervention strategies based on the microbiota-gut-brain axis mechanism.肠道微生物群与自闭症谱系障碍:基于微生物群-肠-脑轴机制的饮食干预策略进展
Front Neurosci. 2025 Jun 4;19:1587818. doi: 10.3389/fnins.2025.1587818. eCollection 2025.
6
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Causation or Association.非酒精性脂肪性肝病与心血管疾病:因果关系还是关联?
Cardiol Rev. 2024;32(5):453-462. doi: 10.1097/CRD.0000000000000537. Epub 2023 Feb 24.
7
Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1α.肠道白细胞介素-33通过对缺氧诱导因子-1α发挥双重调控作用,促进微生物群衍生的氧化三甲胺合成,并驱动代谢功能障碍相关脂肪性肝病进展。
Hepatology. 2024 Jul 10. doi: 10.1097/HEP.0000000000000985.
8
Exploring the gut-exercise link: A systematic review of gastrointestinal disorders in physical activity.探索肠道与运动的关联:对体育活动中胃肠道疾病的系统评价
World J Gastroenterol. 2025 Jun 14;31(22):106835. doi: 10.3748/wjg.v31.i22.106835.
9
Identification and characterisation of a rare variant underlying hereditary non-alcoholic fatty liver disease.遗传性非酒精性脂肪性肝病潜在罕见变异的鉴定与特征分析。
JHEP Rep. 2023 Apr 23;5(8):100764. doi: 10.1016/j.jhepr.2023.100764. eCollection 2023 Aug.
10
Early-life gut inflammation drives sex-dependent shifts in the microbiome-endocrine-brain axis.生命早期的肠道炎症会导致微生物群-内分泌-脑轴发生性别依赖性变化。
Brain Behav Immun. 2025 Mar;125:117-139. doi: 10.1016/j.bbi.2024.12.003. Epub 2024 Dec 12.

本文引用的文献

1
The Role of Diet, Additives, and Antibiotics in Metabolic Endotoxemia and Chronic Diseases.饮食、添加剂和抗生素在代谢性内毒素血症及慢性疾病中的作用
Metabolites. 2024 Dec 13;14(12):704. doi: 10.3390/metabo14120704.
2
The vagus nerve: An old but new player in brain-body communication.迷走神经:脑-体通讯中一个古老却又崭新的角色。
Brain Behav Immun. 2025 Feb;124:28-39. doi: 10.1016/j.bbi.2024.11.023. Epub 2024 Nov 19.
3
Ex vivo and miniaturized in vitro to study microbiota-gut-brain axis.用于研究微生物群-肠-脑轴的体外和小型化体外研究。
3 Biotech. 2024 Nov;14(11):280. doi: 10.1007/s13205-024-04126-z. Epub 2024 Oct 24.
4
Microbiota-derived short chain fatty acids in pediatric health and diseases: from gut development to neuroprotection.微生物群衍生的短链脂肪酸在儿童健康与疾病中的作用:从肠道发育到神经保护
Front Microbiol. 2024 Oct 8;15:1456793. doi: 10.3389/fmicb.2024.1456793. eCollection 2024.
5
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.一种新型低剂量替米沙坦、氨氯地平和吲达帕胺三联单片复方制剂与两种药物联合治疗高血压的疗效和安全性比较:一项随机、双盲、阳性对照、国际临床试验。
Lancet. 2024 Oct 19;404(10462):1536-1546. doi: 10.1016/S0140-6736(24)01744-6.
6
Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review.粪便微生物群移植(FMT)作为一种现代辅助疗法在各种疾病和障碍中的安全性和有效性:综合文献综述。
Front Immunol. 2024 Sep 26;15:1439176. doi: 10.3389/fimmu.2024.1439176. eCollection 2024.
7
Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential.系统性红斑狼疮中的线粒体功能障碍:见解与治疗潜力
Diseases. 2024 Sep 23;12(9):226. doi: 10.3390/diseases12090226.
8
Message Transmission Between Adipocyte and Macrophage in Obesity.肥胖症中脂肪细胞与巨噬细胞之间的信息传递
Adv Exp Med Biol. 2024;1460:273-295. doi: 10.1007/978-3-031-63657-8_9.
9
Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.益生菌、益生元和合生菌对非酒精性脂肪性肝病患者肝酶、血脂谱和炎症的疗效:随机对照试验的系统评价和荟萃分析。
BMC Gastroenterol. 2024 Aug 22;24(1):283. doi: 10.1186/s12876-024-03356-y.
10
Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling.限时喂养通过调节肠道微生物群重塑来改善肝内烟酰胺代谢,从而改善非酒精性脂肪性肝病。
Gut Microbes. 2024 Jan-Dec;16(1):2390164. doi: 10.1080/19490976.2024.2390164. Epub 2024 Aug 18.